Latest Lynx1 Capital Management LP Stock Portfolio
$385Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Lynx1 Capital Management LP and it’s 13F Hedge Fund Stock Holdings
Lynx1 Capital Management LP is a hedge fund based in SAN JUAN, PR. On 03-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $136.4 Millions. In it's latest 13F Holdings report, Lynx1 Capital Management LP reported an equity portfolio of $385.8 Millions as of 31 Mar, 2024.
The top stock holdings of Lynx1 Capital Management LP are ALPN, MRUS, STOK. The fund has invested 23.1% of it's portfolio in ALPINE IMMUNE SCIENCES INC and 17.6% of portfolio in MERUS N V.
The fund managers got completely rid off THESEUS PHARMACEUTICALS INC (THRX) stocks. They significantly reduced their stock positions in ALPINE IMMUNE SCIENCES INC (ALPN), AUTOLUS THERAPEUTICS PLC (AUTL) and PIERIS PHARMACEUTICALS INC (PIRS). Lynx1 Capital Management LP opened new stock positions in CENTESSA PHARMACEUTICALS PLC (CNTA). The fund showed a lot of confidence in some stocks as they added substantially to PASSAGE BIO INC (PASG), SILENCE THERAPEUTICS PLC (SLN) and GH RESEARCH PLC (GHRS).
The top stock holdings of Lynx1 Capital Management LP are ALPN, MRUS, STOK. The fund has invested 23.1% of it's portfolio in ALPINE IMMUNE SCIENCES INC and 17.6% of portfolio in MERUS N V.
The fund managers got completely rid off THESEUS PHARMACEUTICALS INC (THRX) stocks. They significantly reduced their stock positions in ALPINE IMMUNE SCIENCES INC (ALPN), AUTOLUS THERAPEUTICS PLC (AUTL) and PIERIS PHARMACEUTICALS INC (PIRS). Lynx1 Capital Management LP opened new stock positions in CENTESSA PHARMACEUTICALS PLC (CNTA). The fund showed a lot of confidence in some stocks as they added substantially to PASSAGE BIO INC (PASG), SILENCE THERAPEUTICS PLC (SLN) and GH RESEARCH PLC (GHRS).
New Buys
| Ticker | $ Bought |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | 196,620 |
New stocks bought by Lynx1 Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| PASSAGE BIO INC | 1,178 |
| SILENCE THERAPEUTICS PLC | 123 |
| GH RESEARCH PLC | 80.06 |
| MERUS N V | 32.93 |
| STOKE THERAPEUTICS INC | 25.02 |
| C4 THERAPEUTICS INC | 15.96 |
| NEKTAR THERAPEUTICS | 7.24 |
Additions to existing portfolio by Lynx1 Capital Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| ALPINE IMMUNE SCIENCES INC | -40.92 |
| AUTOLUS THERAPEUTICS PLC | -25.2 |
| PIERIS PHARMACEUTICALS INC | -10.2 |
| CABALETTA BIO INC | -1.3 |
| BIONOMICS LIMITED | -1.19 |
| KINNATE BIOPHARMA INC | -0.8 |
Lynx1 Capital Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| THESEUS PHARMACEUTICALS INC | -2,844,780 |
Lynx1 Capital Management LP got rid off the above stocks
Current Stock Holdings of Lynx1 Capital Management LP
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ALPN | ALPINE IMMUNE SCIENCES INC | 23.15 | 2,253,180 | 89,316,200 | REDUCED | -40.92 | |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2.30 | 1,390,160 | 8,869,220 | REDUCED | -25.2 | |
| BNOX | BIONOMICS LIMITED | 0.22 | 814,467 | 838,901 | REDUCED | -1.19 | |
| CABA | CABALETTA BIO INC | 9.21 | 2,082,970 | 35,535,500 | REDUCED | -1.3 | |
| CCCC | C4 THERAPEUTICS INC | 7.70 | 3,634,660 | 29,695,200 | ADDED | 15.96 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 0.05 | 17,400 | 196,620 | NEW | ||
| GHRS | GH RESEARCH PLC | 9.15 | 3,310,560 | 35,290,600 | ADDED | 80.06 | |
| KNTE | KINNATE BIOPHARMA INC | 1.37 | 1,981,110 | 5,269,740 | REDUCED | -0.8 | |
| MRUS | MERUS N V | 17.61 | 1,509,010 | 67,950,600 | ADDED | 32.93 | |
| NKTR | NEKTAR THERAPEUTICS | 0.50 | 2,068,840 | 1,932,710 | ADDED | 7.24 | |
| PASG | PASSAGE BIO INC | 1.70 | 4,845,870 | 6,541,930 | ADDED | 1,178 | |
| PIRS | PIERIS PHARMACEUTICALS INC | 0.42 | 109,740 | 1,608,340 | REDUCED | -10.2 | |
| SLN | SILENCE THERAPEUTICS PLC | 2.95 | 526,642 | 11,375,500 | ADDED | 123 | |
| STOK | STOKE THERAPEUTICS INC | 12.94 | 3,696,820 | 49,907,100 | ADDED | 25.02 | |
| TCRX | TSCAN THERAPEUTICS INC | 10.75 | 5,224,600 | 41,483,300 | UNCHANGED | 0.00 | |
| THRX | THESEUS PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |